Literature DB >> 19160307

Techniques for liver parenchymal transection in liver resection.

Kurinchi Selvan Gurusamy1, Viniyendra Pamecha, Dinesh Sharma, Brian R Davidson.   

Abstract

BACKGROUND: Blood loss during elective liver resection is one of the main factors affecting the surgical outcome. Different parenchymal transection techniques have been suggested to decrease blood loss.
OBJECTIVES: To assess the benefits and risks of the different techniques of parenchymal transection during liver resections. SEARCH STRATEGY: We searched The Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE, EMBASE, and Science Citation Index Expanded (March 2008). SELECTION CRITERIA: We considered for inclusion all randomised clinical trials comparing different methods of parenchymal dissection irrespective of the method of vascular occlusion or any other measures used for lowering blood loss. DATA COLLECTION AND ANALYSIS: Two authors identified the trials and extracted the data on the population characteristics, bias risk, mortality, morbidity, blood loss, transection speed, and hospital stay independently of each other. We calculated the odds ratio (OR), mean difference (MD), or standardised mean difference (SMD) with 95% confidence intervals based on 'interntion-to-treat analysis' or 'available case analysis' using RevMan 5. MAIN
RESULTS: We included seven trials randomising 556 patients. The comparisons include CUSA (cavitron ultrasound surgical aspirator) versus clamp-crush (two trials); radiofrequency dissecting sealer (RFDS) versus clamp-crush (two trials); sharp dissection versus clamp-crush technique (one trial); and hydrojet versus CUSA (one trial). One trial compared CUSA, RFDS, hydrojet, and clamp-crush technique. The infective complications and transection blood loss were greater in the RFDS than clamp-crush. There was no difference in the blood transfusion requirements, intensive therapy unit (ITU) stay, or hospital stay in this comparison. There was no significant differences in the mortality, morbidity, markers of liver parenchymal injury or liver dysfunction, ITU, or hospital stay in the other comparisons. The blood transfusion requirements were lower in the clamp-crush technique than CUSA and hydrojet. There was no difference in the transfusion requirements of clamp-crush technique and sharp dissection. Clamp-crush technique is quicker than CUSA, hydrojet, and RFDS. The transection speed of sharp dissection and clamp-crush technique was not compared. There was no clinically or statistically significant difference in the operating time between sharp dissection and clamp-crush techniques. Clamp-crush technique is two to six times cheaper than the other methods depending upon the number of surgeries performed each year. AUTHORS'
CONCLUSIONS: Clamp-crush technique is advocated as the method of choice in liver parenchymal transection because it avoids special equipment, whereas the newer methods do not seem to offer any benefit in decreasing the morbidity or transfusion requirement.

Entities:  

Mesh:

Year:  2009        PMID: 19160307     DOI: 10.1002/14651858.CD006880.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  45 in total

1.  Low-dose steroid pretreatment ameliorates the transient impairment of liver regeneration.

Authors:  Toshihito Shibata; Toru Mizuguchi; Yukio Nakamura; Masaki Kawamoto; Makoto Meguro; Shigenori Ota; Koichi Hirata; Hidekazu Ooe; Toshihiro Mitaka
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Differences between bipolar compression and ultrasonic devices for parenchymal transection during laparoscopic liver resection.

Authors:  Nsehniitooh A Mbah; Russell E Brown; Matthew R Bower; Charles R Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  HPB (Oxford)       Date:  2012-02       Impact factor: 3.647

3.  Conformational technique for non-anatomic resection of liver lesions.

Authors:  Peter J Dipasco; Subhasis Misra; Leonidas G Koniaris
Journal:  J Gastrointest Surg       Date:  2012-07-11       Impact factor: 3.452

4.  The impact of portal pedicle clamping on survival from colorectal liver metastases in the contemporary era of liver resection: a matched cohort study.

Authors:  Melanie E Tsang; Paul J Karanicolas; Rogeh Habashi; Eva Cheng; Sherif S Hanna; Natalie G Coburn; Calvin H L Law; Julie Hallet
Journal:  HPB (Oxford)       Date:  2015-09       Impact factor: 3.647

5.  Cost-Effective Surgical Management of Liver Disease Amidst a Financial Crisis.

Authors:  Nikolaos Arkadopoulos; Georgios Gemenetzis; Nikolaos Danias; Panagiotis Kokoropoulos; Ioanna Koukopoulou; Christos Bartsokas; Georgia Kostopanagiotou; Vassilios Smyrniotis
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

6.  Natural orifice transluminal endoscopic wedge hepatic resection with a water-jet hybrid knife in a non-survival porcine model.

Authors:  Hong Shi; Sheng-Jun Jiang; Bin Li; Deng-Ke Fu; Pei Xin; Yong-Guang Wang
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

7.  Robot-assisted parenchymal-sparing liver surgery including lesions located in the posterosuperior segments.

Authors:  Luciano Casciola; Alberto Patriti; Graziano Ceccarelli; Alberto Bartoli; Cecilia Ceribelli; Alessandro Spaziani
Journal:  Surg Endosc       Date:  2011-06-08       Impact factor: 4.584

8.  MILS in a general surgery unit: learning curve, indications, and limitations.

Authors:  Alberto Patriti; Luigi Marano; Luciano Casciola
Journal:  Updates Surg       Date:  2015-07-12

Review 9.  Laparoscopic surgery of liver tumors.

Authors:  Johanna Kirchberg; Christoph Reißfelder; Jürgen Weitz; Moritz Koch
Journal:  Langenbecks Arch Surg       Date:  2013-09-18       Impact factor: 3.445

10.  IVC CLAMP: infrahepatic inferior vena cava clamping during hepatectomy--a randomised controlled trial in an interdisciplinary setting.

Authors:  Nuh N Rahbari; Johannes B Zimmermann; Moritz Koch; Thomas Bruckner; Thomas Schmidt; Heike Elbers; Christoph Reissfelder; Markus A Weigand; Markus W Büchler; Jürgen Weitz
Journal:  Trials       Date:  2009-10-13       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.